va-Q-tec IPO

Supervisory Board

Dr. Gerald Hommel​​

Dr. Gerald Hommel,
Supervisory Board Chairman (appointed until 2023)

  • Born on 21 January 1959, German citizen
  • Undergraduate study of economic sciences at the universities of Mainz and Würzburg, degree in business management (1985)
  • 1985 - 1997 Pharmaceutical wholesaling, most recently Managing Director at PHOENIX Pharma Einkauf GmbH, Dreieich
  • 1997 - 1999 Management Board member of GESKO eG, Gerlingen (purchasing cooperative)
  • Independent pharmaceuticals entrepreneur since 1999
  • Independent pharmaceuticals entrepreneur and Managing Shareholder of pharmarissano Arzneimittel GmbH since 2004
  • Doctorate in economic and social history from the University of Frankfurt am Main (2014)
  • Dr. Hommel is Chairman of the Nomination Committee, Chairman of the General Committee and Deputy Chairman of the Audit Committee of the Supervisory Board.
  • Dr. Hommel does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.

Dr. Barbara Ooms-Gnauck​​

  Dr. Barbara Ooms-Gnauck,
Deputy Chairwoman of the Supervisory Board (appointed until 2023)

  • Born on 28 October 1957, Belgian citizen
  • Study of chemistry and ecototrophology at the University of Bonn, degree in ecototrophology (1983)
  • Study of jurisprudence of the University of Göttingen, First State Examination (2001)
  • Probationary Training Period at the District Court of Kassel, Second State Examination (2004)
  • Attorney (2004)
  • 2005 - 2010 Attorney, partner at GKMP Rechtsanwälte Steuerberater Wirtschaftsprüfer
  • Shareholder in and attorney at Gnauck Rechtsanwälte GbR since 2010
  • Doctorate awarded by the University of Constance (2012)
  • Specialist lawyer for administration law (2016)
  • Dr. Ooms-Gnauck is a member of the Nomination and General committees of the Supervisory Board.
  • Dr. Ooms-Gnauck does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.

Uwe Andreas Krämer​​​

Uwe Andreas Krämer​,
(appointed until 2023)

  • Born on 27 October 1978, German citizen
  • Degree in business information technology from the Technical University of Darmstadt (2006)
  • 2006 – 2008: Investment Banking Division, Goldman Sachs, Frankfurt
  • 2008 – 2014: Venture & growth capital investment professional focusing on software and internet technology, ViewPoint Capital, Frankfurt/Zürich
  • 2016 – 2018 Managing Director & CFO/CCO of enterprise software company Fision AG, Zürich
  • Since 2014 growth capital investor focusing on cleantech, Zouk Capital, London
  • Since 2018 Vice President Finance & Operations of enterprise software company Scandit AG, Zürich
  • Mr. Krämer is a member of the Nomination Committee of the Supervisory Board.
  • Mr. Krämer does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.

Winfried Klar​​

Winfried Klar,
(appointed until 2023)

  • Born on 10 October 1954, German citizen
  • Degree in business administration from the University of Münster (1979)
  • Auditor and tax consultant PwC Dusseldorf (1980-1990)
  • 1991 - 1992 Head of Group development EVONIK (formerly RAG)
  • 1993 - 2003 Managing Director, Management Board member, CFO at various companies
  • 2004 - 2009: Managing Director and CFO of VESTOLIT GmbH & Co KG, Marl
  • 2009 - 2013: Managing Director and CFO of MAUSER Holding GmbH, Brühl
  • 2013 - 2019: management consulting in the Middle East, KMC Klar Management Consultancies, Dubai
  • Mr. Klar has been the Chairman of the Audit Committee of the Supervisory Board since 2016.
  • Mr. Klar does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.

Dr. Eberhard Kroth​​

Dr. Eberhard Kroth,
(appointed until 2023)

  • Born on 15 June 1956, German citizen
  • Undergraduate studies and doctorate at the Technical University of Darmstadt (1985)
  • 1986 - 1994 Company officer and Technical Director at Reis Robotics, Reis GmbH & Co KG
  • 1994 - 2010 Managing Director at Reis Robotics, Reis GmbH & Co KG
  • 2010 - 2016 Managing Director at Reis Group Holding GmbH
  • 2015 - 2016 Managing Director & Chief Technical Officer (CTO) of KUKA Industries GmbH
  • Since 2017 Managing Shareholder of RoPro4.0 GmbH, automation technology
  • Dr. Kroth is a member of the Audit Committee.
  • Dr. Kroth does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.

Dr. Burkhard Wichert​​

Dr. Burkhard Wichert,
(appointed until 2023)

  • Born 05 December 1961, German citizen
  • Place of residence: Bielefeld (North Rhine-Westphalia)
  • Member of the Supervisory Board since 2021
  • Studied pharmacy at the Westfälische Wilhelms University in Münster (1987)
  • Doctorate in pharmaceutical technology (1989)
  • 1990 - 2001 various positions in research and development and production at ASTA Medica
  • 2002 - 2016 various positions in operations including commercial and operational head of global contract manufacturing at Baxter Halle (Westphalia, Germany)
  • MBA from Buckinghamshire Chilterns University College (2007)
  • 2016 - 2019 head of operations EMEA at Baxter Zurich
  • Since 2019 founder and managing director of pos pharma GmbH
  • Dr. Wichert does not hold any further mandates on statutory Supervisory Boards or comparable German or foreign controlling entities of commercial enterprises.